Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

3 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

dbGaP phs001293 NHLBI TOPMed: HyperGEN - Genetics of Left Ventricular (LV) Hypertrophy - Eligibility

- 09/05/23 - 6 moduli, 1 ItemGroup, 1 elemento, 1 linguaggio
ItemGroup: IG.elig
Principal Investigator: Donna K. Arnett, PhD, School of Public Health, University of Kentucky, Lexington, KY, USA MeSH: Hypertrophy, Left Ventricular,Antihypertensive Agents,Blood Pressure,Diastolic Pressure,Echocardiography,Heart Atria,Heart Ventricles,Hypertension,Stroke Volume,Systolic Pressure,Ventricular Dysfunction, Left,Ventricular Ejection Fraction,Ventricular Function, Left,Ventricular Remodeling https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001293 The Hypertension Genetic Epidemiology Network Study (HyperGEN) - Genetics of Left Ventricular (LV) Hypertrophy is a familial study aimed to understand genetic risk factors for LV hypertrophy by conducting genetic studies of continuous traits from echocardiography exams. The originating HyperGEN study aimed to understand genetic risk factors for hypertension. Data from detailed clinical exams as well as genotyping data for linkage studies, candidate gene studies and GWAS have been collected and is shared between HyperGEN and the ancillary HyperGEN - Genetics of LV Hypertrophy study.

pht008893.v1.p1

1 ItemGroup 5 elementi

pht008894.v1.p1

1 ItemGroup 6 elementi

pht008896.v1.p1

1 ItemGroup 142 elementi

pht008897.v1.p1

1 ItemGroup 9 elementi

pht008895.v1.p1

1 ItemGroup 2 elementi

Eligibility Left Ventricular Ejection Fraction NCT00388245

- 15/05/18 - 1 modulo, 2 itemgroups, 21 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Revascularization in Heart Failure Trial – REHEAT 2; ODM derived from: https://clinicaltrials.gov/show/NCT00388245

Eligibility Advanced Refractory Left Ventricular Heart Failure NCT02170363

- 29/04/16 - 1 modulo, 2 itemgroups, 38 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Thoratec Corporation HeartMate III™ CE Mark Clinical Investigation Plan; ODM derived from: https://clinicaltrials.gov/show/NCT02170363

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial